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Congenital heart disease due to environmental teratoppns. 
The thalidomide tragedy brought about the wdden rraliw 
tion that “the human embryo was not requestered m on 
impervious maternal body where it was shielded from all but 
genetic harm” (I). Consequent anxiety re&?rdX$ en”~r”“- 
mental teratogens triggered a” international comn~tmsn~ to 
malformaaor! urveillancc with an urga~,:i-?. damc~~ I” 
possible similar occurrences (2). The malfor,rma innt chosen 
as “sentinels” were those most reliably recogmzed at birth 
and, until recently (3.4). congenital heart disease wn’85 not 
amongthem. The reason for lhis is Ihe difficulty in diagoostic 
ascelainment: neonatal indicators of d cardiovascular mnl- 
formation may be very subtle. infants might die after birth 
without recognition of their heart disease and infants with 
neonatal distress require special studies in tertiary care 
centers to resolve the differential diagnosis of cardiac or 
pu!m”nary causes. Thus. the “view” from the pediatric 
cardiology center includes a very selected we group. 
Epidemiologists who are searching for causes seek a dif- 
ferent view and must lake into account every p”tcn&d biea 
before making comparisons of regional birth prevalences. 
The study by Mayberry et al. (5) in this issue of the Journal 
illustrates the magnitude of !his problem. The variations and 
poiential changes in the observation time in only four 
categories of relevant factors indicate the necessary cautiun. 
I, Popuhrion ficro,~. such as migndon, race/ethnaity 
with cultural socioeconomic and genetic dilferences includ- 
ing consanguinity may alter predisposition to anomalier. 
exposure likelihood. access to and use of medical care. 
2. Family Judors. such as maternal age. reproductive 
history (fetal loss. low birth weight. infant mortality) may 
alter the medical care rought and received. 
The present study. 4lthou:h mo~l of that isw? wore 
not con\idercd in the study uf Mayberry cf dl. (51, the 
men~m of a pedmirtc c ardl”!oeg center !” ev,d”aw regional 
rcfcrral d~ffcrcncca i\ a commcndirblc cxamplc for & ‘pc- 
c,id,y \cr\,cc, bccausc I, could xomotc the \c.lrch for wa)? 
I” op:imwe ,ICCCM to Ihe bc\t po\sihle care for all a!?L:c.! 
mfanl\ and children. Ttw cornpan\“” of prevalence in the 
Yuma sod Swra Vista uear is handicapped by small nom- 
berr and bv the introdwim of two-dimensional echocardio- 
grsphir d&osi, that virudly comcided wth the “nxl of 
the \ladv oenod (Is83 tc 1988). Thn chance m diaenostic 
method may be resp”n*ibl: for rhe steeply r&g prcvalenccs 
in both arca, shown in their Table I. Without an a~cr~ment 
“ftbn and “therrourcrs~~fascenainmen~ bias. aconclotion 
of different environmenta! factors could not be suppurted. 
Cwnpwison with “tber rpidemiologir studios. The Balti- 
more-l\‘athangton Infant Study, an epidemiologic investw 
don of conpn~tal heart di>easr (6). i5 referred 1” by Mny- 
hrrry et id. (5) and ha been quoted by others but ihe 
cornpar,\““\ to other ilrea prevalencec were not always 
appropware because of dSereoces in asccnainment mcth- 
od,. care definitions including ag.e of diagnosis. diagnostic 
e~cl”sions snd stulv wars of different levels of pediatric 
cardiology expertise &IO). Although modeled after the 
New England Regional Infant Cardiac Program I’). the birth 
prcvalencc of congenital henn disease in the Baltimore- 
Washingron lniant Study’s first report 161 (I981 1” 1982) 
already cwxdrd that obtained in New Englmd in 1969 to 
1977. Keccnr studies of other authors that were similar in 
msthodclogy and timing showed similar rewlts (11.12) but 
the oroblem\ of differentnl ascertainment were rmooasized 
in each. 
With all methods constant io rhe Baltimore-Washington 
area. secular changes have yie!ded oew insights into the 
fragility uf prevalence-ill-livchinh determinations bared on 
dia8now\ from infancy. The increase in congenital heart 
diaruc “ccurrcnce in 1983 to 19U4 was due to improved 
detection techniques by two-dimensional and Doppler echo- 
cardiography (13) and in 1985 to 1986 sldl more healthy 
mfanta wcrc referred for this dlngnostlc confirmation (14). 
However. the 6 year rewlt~ ils” demonstrated the relative 
stability of prevalence for uniformly diagnosed sevcw mal- 
formations such as transposition of the great arteries and 
total anomalous pulmonary vennus return and a slight down- 
ward trend in the prevalence of hypoplastic left heart syn- 
dromc and double outlet right ventricle probably due to 
expandiilg use of retal t;krasonography and pregnancy ter- 
mination. Moreover, the impact of these evolving medical 
practices was not uniformly distributed. An evaluation of 
white-black diffetentials in infanl heart disease by socioeco- 
nomic factors, won lo be reported by Correa-Villasenor, has 
revealed the impact of several societal dilferencer that could 
totally overshadow the subtle effects of teratogens. 
Implicztkms. With all these caveats orw might ask: 
“Why measure congenital heart disease prevalence?” As 
cardiologists, we wish to know of each infant with a cardio- 
vascula malformation. Iniormation that could improve ma- 
ternal and child health in our communities would constitute 
zdequa!e justification and heighten wareness of many is. 
sues that had previously escaped our attention. Detailed 
evaluations of birth defect monitcting programs (2.15) pro- 
vide compelling arguments for such systenaized account- 
ing, with periodic evaluations of changes within and across 
monitoring systems. At the least, they would facilitate the 
planning and effective xnduct of case-control investiga- 
tions, some based on possible chtstering of cases, increases 
or decreases or stimulated by changes in the environment, 
suck 8s exposure to nuclear radiation or water contamina- 
tion (16). The surveillance system implies a sto!e of readi- 
ness and a clearer comprehension of community issue3 than 
we have ever had in the past. Epidemiologic assessment of 
cardiovascular malformations, in contrast with that of adult 
heart disease, is still vety underdeveloped. The ongoing 
improvement and refinement of studies such as that of 
Mayberry et al. (5) could eventually establish a national 
network ofpowerful capability in improving patient care and 
in reci ?niz;ng risk factors that, in turn, could lead to the 
prevention of some cardiovascular malformations. 
